January 31st 2023
A panel of distinguished experts discuss how detection of actionable mutations affect their treatment choices in non-small cell lung cancer.
David Spigel, MD, and David H. Harpole Jr, MD, describe when adjuvant therapy is recommended in early stage NSCLC and discuss data from recent clinical trials of adjuvant therapy.
January 24th 2023
A panel of experts in the treatment of NSCLC discusses how they manage patients with stage IB disease.
David H. Harpole Jr, MD, a thoracic surgeon, details his workup approach and discussed molecular testing for patients who present with NSCLC.
January 17th 2023
David Spigel, MD, presents a patient case of a 57-year-old woman with NSCLC, and Jaspal Singh, MD, MHS, discusses his approach to initial evaluation.
A panel of experts introduce themselves and explain their approaches to multidisciplinary care in treating non-small cell lung cancer.